Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21290210)

  • 1. Chemotherapeutic agents in low noncytotoxic concentrations increase immunogenicity of human colon cancer cells.
    Kaneno R; Shurin GV; Kaneno FM; Naiditch H; Luo J; Shurin MR
    Cell Oncol (Dordr); 2011 Apr; 34(2):97-106. PubMed ID: 21290210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.
    Shurin GV; Tourkova IL; Kaneno R; Shurin MR
    J Immunol; 2009 Jul; 183(1):137-44. PubMed ID: 19535620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemomodulation of human dendritic cell function by antineoplastic agents in low noncytotoxic concentrations.
    Kaneno R; Shurin GV; Tourkova IL; Shurin MR
    J Transl Med; 2009 Jul; 7():58. PubMed ID: 19591684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LMP7-K allele of the immunoproteasome exhibits reduced transcript stability and predicts high risk of colon cancer.
    Fellerhoff B; Gu S; Laumbacher B; Nerlich AG; Weiss EH; Glas J; Kopp R; Johnson JP; Wank R
    Cancer Res; 2011 Dec; 71(23):7145-54. PubMed ID: 22037870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of antigen-specific cytotoxic T lymphocytes by beta 2-microglobulin or TAP1 gene disruption and the introduction of recipient-matched MHC class I gene in allogeneic embryonic stem cell-derived dendritic cells.
    Matsunaga Y; Fukuma D; Hirata S; Fukushima S; Haruta M; Ikeda T; Negishi I; Nishimura Y; Senju S
    J Immunol; 2008 Nov; 181(9):6635-43. PubMed ID: 18941254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen-processing machinery in human dendritic cells: up-regulation by maturation and down-regulation by tumor cells.
    Whiteside TL; Stanson J; Shurin MR; Ferrone S
    J Immunol; 2004 Aug; 173(3):1526-34. PubMed ID: 15265880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bipartite regulation of different components of the MHC class I antigen-processing machinery during dendritic cell maturation.
    Li J; Schuler-Thurner B; Schuler G; Huber C; Seliger B
    Int Immunol; 2001 Dec; 13(12):1515-23. PubMed ID: 11717192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MHC class I-deficient metastatic tumor variants immunoselected by T lymphocytes originate from the coordinated downregulation of APM components.
    Garcia-Lora A; Martinez M; Algarra I; Gaforio JJ; Garrido F
    Int J Cancer; 2003 Sep; 106(4):521-527. PubMed ID: 12845647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional deficiencies of components of the MHC class I antigen pathway in human tumors of epithelial origin.
    Delp K; Momburg F; Hilmes C; Huber C; Seliger B
    Bone Marrow Transplant; 2000 May; 25 Suppl 2():S88-95. PubMed ID: 10933198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IFN-γ enhances the anti-tumour immune response of dendritic cells against oral squamous cell carcinoma.
    Wei H; Hongya P; Linlin J; Mujiang A; Kuijie W; Duohong Z; Qingang H; Zhiyuan Z
    Arch Oral Biol; 2011 Sep; 56(9):891-8. PubMed ID: 21474117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IFN-beta mediates coordinate expression of antigen-processing genes in RSV-infected pulmonary epithelial cells.
    Jamaluddin M; Wang S; Garofalo RP; Elliott T; Casola A; Baron S; Brasier AR
    Am J Physiol Lung Cell Mol Physiol; 2001 Feb; 280(2):L248-57. PubMed ID: 11159003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
    Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
    Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly decreased expression of TAP1 and LMP2 genes in HLA class I-deficient human tumor cell lines.
    Singal DP; Ye M; Ni J; Snider DP
    Immunol Lett; 1996 May; 50(3):149-54. PubMed ID: 8803612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Processing of a multiple membrane spanning Epstein-Barr virus protein for CD8(+) T cell recognition reveals a proteasome-dependent, transporter associated with antigen processing-independent pathway.
    Lautscham G; Mayrhofer S; Taylor G; Haigh T; Leese A; Rickinson A; Blake N
    J Exp Med; 2001 Oct; 194(8):1053-68. PubMed ID: 11602636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.
    Schnurr M; Galambos P; Scholz C; Then F; Dauer M; Endres S; Eigler A
    Cancer Res; 2001 Sep; 61(17):6445-50. PubMed ID: 11522639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The B subunit of Shiga toxin fused to a tumor antigen elicits CTL and targets dendritic cells to allow MHC class I-restricted presentation of peptides derived from exogenous antigens.
    Haicheur N; Bismuth E; Bosset S; Adotevi O; Warnier G; Lacabanne V; Regnault A; Desaymard C; Amigorena S; Ricciardi-Castagnoli P; Goud B; Fridman WH; Johannes L; Tartour E
    J Immunol; 2000 Sep; 165(6):3301-8. PubMed ID: 10975847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic changes within the promoter regions of antigen processing machinery family genes in Kazakh primary esophageal squamous cell carcinoma.
    Sheyhidin I; Hasim A; Zheng F; Ma H
    Asian Pac J Cancer Prev; 2014; 15(23):10299-306. PubMed ID: 25556465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteasome, transporter associated with antigen processing, and class I genes in the nurse shark Ginglymostoma cirratum: evidence for a stable class I region and MHC haplotype lineages.
    Ohta Y; McKinney EC; Criscitiello MF; Flajnik MF
    J Immunol; 2002 Jan; 168(2):771-81. PubMed ID: 11777971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor-alpha induces coordinated changes in major histocompatibility class I presentation pathway, resulting in increased stability of class I complexes at the cell surface.
    Hallermalm K; Seki K; Wei C; Castelli C; Rivoltini L; Kiessling R; Levitskaya J
    Blood; 2001 Aug; 98(4):1108-15. PubMed ID: 11493458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.